Drug Profile
Psorox
Alternative Names: Exorias; PsorexLatest Information Update: 26 Jun 2003
Price :
$50
*
At a glance
- Originator Conpharm
- Class Antipsoriatics
- Mechanism of Action Microtubule protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psoriasis
Most Recent Events
- 31 Dec 2001 Discontinued - Phase-III for Psoriasis in Sweden (Topical)
- 15 Dec 2000 Psorox is available for licensing
- 22 Sep 1997 Phase-III clinical trials for Psoriasis in Sweden (Topical)